CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $285,000 | -98.5% | 11,500 | -98.5% | 0.00% | -98.3% |
| Q1 2022 | $19,605,000 | -35.6% | 781,994 | -6.5% | 0.06% | -10.8% |
| Q4 2021 | $30,458,000 | +2051.0% | 836,535 | +910.3% | 0.06% | +2066.7% |
| Q3 2021 | $1,416,000 | -59.7% | 82,800 | -68.5% | 0.00% | -62.5% |
| Q2 2021 | $3,516,000 | -38.9% | 262,600 | +150.2% | 0.01% | -60.0% |
| Q3 2020 | $5,752,000 | -66.3% | 104,965 | -64.6% | 0.02% | -76.5% |
| Q2 2020 | $17,074,000 | +872.3% | 296,731 | +578.9% | 0.08% | +507.1% |
| Q1 2020 | $1,756,000 | -12.1% | 43,710 | -13.4% | 0.01% | +133.3% |
| Q4 2019 | $1,997,000 | +159.0% | 50,486 | -55.6% | 0.01% | +100.0% |
| Q3 2019 | $771,000 | -51.4% | 113,677 | -33.4% | 0.00% | -40.0% |
| Q2 2019 | $1,587,000 | -50.8% | 170,640 | -26.5% | 0.01% | -50.0% |
| Q1 2019 | $3,226,000 | +465.0% | 232,256 | +343.6% | 0.01% | +400.0% |
| Q4 2018 | $571,000 | -67.9% | 52,362 | -62.8% | 0.00% | -60.0% |
| Q3 2018 | $1,779,000 | -47.6% | 140,781 | -45.4% | 0.01% | -50.0% |
| Q2 2018 | $3,395,000 | +116.9% | 257,773 | +124.0% | 0.01% | +100.0% |
| Q1 2018 | $1,565,000 | +890.5% | 115,073 | +80.9% | 0.01% | +400.0% |
| Q1 2016 | $158,000 | -40.2% | 63,617 | +95.5% | 0.00% | 0.0% |
| Q4 2015 | $264,000 | +20.0% | 32,537 | +1.0% | 0.00% | 0.0% |
| Q4 2014 | $220,000 | -50.6% | 32,220 | -58.0% | 0.00% | -50.0% |
| Q4 2013 | $445,000 | – | 76,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |